SHShintaro Hashimoto

Shintaro Hashimoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shintaro Hashimoto has a total of 97 co-authors. Here are the top co-authors by number of shared publications:

  • Takashi Nonaka

    Division of Surgical Oncology, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    13 shared publications
  • Toshio Shiraishi

    Division of Surgical Oncology, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    13 shared publications
  • Keisuke Noda

    Division of Surgical Oncology, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    12 shared publications
  • Tetsuro Tominaga

    Division of Surgical Oncology, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    12 shared publications
  • Hidetoshi Fukuoka

    Department of Surgery, Isahaya General Hospital , 23-23 Eisho, Isahaya 854-0072

    10 shared publications
  • Rika Ono

    Department of Surgery, Sasebo General Hospital, Nagasaki, Japan

    10 shared publications

Latest Publications

  • Open Access

    Oncological outcomes of robotic versus laparoscopic colectomy for colon cancer: a propensity score–matched study focusing on peritoneal recurrence

    by Takashi Nonaka, Keisuke Noda, Tetsuro Tominaga, Hiroki Katayama, Shintaro Hashimoto, Makoto Hisanaga, Hiroaki Takeshita, Kazuo To, Hidetoshi Fukuoka, Keitaro Matsumoto

    Purpose: To compare perioperative and oncologic outcomes between robotic and laparoscopic colectomy for colon cancer, with a focus on peritoneal recurrence, using a propensity score–matched analysis.Methods: We retrospectively reviewed 591 patients who underwent minimally invasive colectomy for colon cancer between 2016 and 2024. After 1:1 propensity score matching based on age, sex, body mass index, American Society of Anesthesiologists physical status, clinical stage, and procedure, 90 patients in each group were analyzed. Survival outcomes were assessed using Kaplan-Meier methods and competing risk analysis with the Fine-Gray model.Results: Robotic colectomy showed lower blood loss (median, 10 mL vs. 20 mL; P<0.001), shorter postoperative hospital stay (median, 9 days vs. 11.5 days, P<0.001), and a higher rate of intracorporeal anastomosis (92.2% vs. 24.4%, P<0.001), without prolonging operative time. Disease-free survival was comparable (P=0.519). Locoregional/peritoneal recurrence-free survival was higher in the robotic group (P=0.037); however, competing risk analysis using the Fine-Gray model showed no significant difference in the cumulative incidence of locoregional/peritoneal recurrence between groups. Multivariable analysis identified high-grade histology as an independent predictor of peritoneal recurrence, whereas surgical approach was not.Conclusion: Robotic colectomy provides favorable perioperative outcomes while maintaining oncologic safety comparable to laparoscopic colectomy. Peritoneal recurrence appears to be driven primarily by tumor biology, and intracorporeal anastomosis does not increase recurrence risk.

  • ASO Visual Abstract: Salvage R0 Resection on Post-Recurrence Survival After Pulmonary Metastasectomy for Colorectal Cancer: A Multicenter Retrospective Study

    by Shintaro Hashimoto, Tetsuro Tominaga, Toshio Shiraishi, Keisuke Noda, Mariko Yamashita, Hiroki Katayama, Yuma Takamura, Satoshi Mizoguchi, Tomohiro Obata, Daisuke Taniguchi, et al.

  • Recurrence-free survival in patients with stage III colorectal cancer who did or did not complete adjuvant chemotherapy

    by Shintaro Hashimoto, Toshio Shiraishi, Tetsuro Tominaga, Keisuke Noda, Mariko Yamashita, Hiroki Katayama, Hiroshi Maruta, Yuma Takamura, Hideaki Komatsu, Kenji Tanaka, et al.

    Purpose To evaluate the impact of adjuvant chemotherapy continuity on the recurrence-free survival in real-world patients with stage III colorectal cancer. Methods We retrospectively analyzed 281 patients with pathologic stage III colorectal cancer who underwent curative resection at two institutions in Japan. Patients were classified into three groups according to their adjuvant chemotherapy status: completion, discontinuation, or no initiation. Recurrence-free survival was compared between the groups. Factors associated with treatment discontinuation were assessed using a multivariable logistic regression analysis. Results Among the 159 patients who initiated adjuvant chemotherapy, 116 (73.0%) completed the planned course. Completion was associated with a significantly better recurrence-free survival than discontinuation (5-year recurrence-free survival 77.6% vs. 56.5%, p=0.013). Recurrence-free survival in the discontinuation group was similar to that in patients without chemotherapy (56.5% vs. 55.8%, p=0.498). Severe adverse events (CTCAE grade 3 or higher) were independently associated with treatment discontinuation (odds ratio 6.658, 95% confidence interval 2.807–16.740, p<0.001). Most discontinuations occurred within the first three months (78.9%). In patients who initiated chemotherapy, discontinuation was independently associated with a poorer recurrence-free survival (RFS). Conclusions Completion of adjuvant chemotherapy was associated with an improved recurrence-free survival, whereas early discontinuation, largely driven by severe toxicity, was associated with inferior survival outcomes.

  • Salvage R0 Resection on Post-Recurrence Survival After Pulmonary Metastasectomy for Colorectal Cancer: A Multicenter Retrospective Study

    by Shintaro Hashimoto, Tetsuro Tominaga, Toshio Shiraishi, Keisuke Noda, Mariko Yamashita, Hiroki Katayama, Yuma Takamura, Satoshi Mizoguchi, Tomohiro Obata, Daisuke Taniguchi, et al.


  • Open Access

    Surgical and oncologic outcomes of cT4b rectal cancer: a propensity score–matched comparison between a university center and regional hospitals

    by Takashi Nonaka, Keisuke Noda, Tetsuro Tominaga, Hiroki Katayama, Shintaro Hashimoto, Makoto Hisanaga, Hiroaki Takeshita, Kazuo To, Hidetoshi Fukuoka, Keitaro Matsumoto

    Purpose: Surgery for cT4b rectal cancer remains technically demanding, and outcomes may vary substantially across institutions. This study evaluated perioperative and oncologic outcomes of cT4b rectal cancer surgery performed at a university center compared with those at regional hospitals within a collaborative network.Methods: A total of 103 patients who underwent curative-intent surgery for cT4b rectal cancer between 2016 and 2024 were retrospectively reviewed. After 1:1 propensity score matching based on baseline characteristics and treatment factors, 54 patients were included in the analysis. Perioperative outcomes, pathological findings, and long-term oncologic outcomes were compared between the university hospital and affiliated regional institutions. Overall survival, relapse-free survival, and local control rate were additionally evaluated in patients with pathological stage II–III disease.Results: Postoperative hospital stay was significantly shorter at the university center (18 days vs. 25 days, P=0.022). Local control was higher in the university hospital group (3-year local control rate: 95.2% vs. 71.5%, P=0.025). Among patients with pathological stage II–III disease, 3-year relapse-free survival was comparable between groups (51.8% vs. 49.0%, P=0.434), whereas local control demonstrated a favorable trend in the university hospital group (91.7% vs. 65.4%, P=0.063).Conclusion: Perioperative safety in cT4b rectal cancer surgery was comparable across institutions; however, higher local control at the university center suggests that technically complex cases may benefit from selective centralization in specialized centers. These findings support a hybrid model in which regional collaboration ensures safety while advanced procedures are concentrated in specialized centers.

  • Impact of severe postoperative complications on oncologic outcomes after curative resection for stage I–III colorectal cancer: a multicenter study

    by Shintaro Hashimoto, Tetsuro Tominaga, Keisuke Noda, Toshio Shiraishi, Hiroki Katayama, Shoko Tei, Taiji Hida, Kazuki Motoyama, Shoto Yamazaki, Takashi Ohnoda, et al.

    Background: Severe postoperative complications (Clavien–Dindo [CD] grade ≥ 3) may compromise long-term oncologic outcomes after colorectal cancer (CRC) surgery, but their impact across all pathological stages remains unclear. Methods: We retrospectively analyzed 1990 patients who underwent curative resection for pStage I–III CRC at six hospitals (2016–2021). Multivariable Cox proportional hazards models were used to evaluate recurrence-free survival (RFS), overall survival (OS), cancer-specific survival (CSS), and time to recurrence (TTR). Stratified analyses were performed by pathological stage and complication type (intra-abdominal infectious complications [IAI] vs. non-IAI), and a 30-day landmark analysis was conducted. Results: CD ≥3 complications occurred in 128 patients (6.4%). On multivariable analysis, CD ≥3 complications were independent adverse prognostic factors for RFS (hazard ratio [HR] 1.84, P < .001), OS (HR 2.52, P < .001), and CSS (HR 2.04, P = .024), but not for TTR (HR 1.22, P = .451). Stage-stratified analyses showed significant associations with worse RFS and OS in pStage II-III, with trends in pStage I. CSS was significantly worse in pStage III (HR 3.06, P < .001). TTR showed no significant association with CD ≥3 complications in any pStage. IAI complications were independently associated with worse CSS (HR 2.21, P = .039), whereas non-IAI complications were not. These adverse effects persisted after 30-day landmark analysis. Conclusions: CD ≥3 complications independently worsen RFS, OS, and CSS but do not significantly affect TTR after curative resection for pStage I–III CRC. IAI complications are particularly associated with worse cancer-specific mortality. This discordance suggests that severe complications may not primarily accelerate recurrence itself, but may instead impair survival after recurrence, highlighting possible mechanisms beyond direct recurrence acceleration.

  • Risk factors for one-year mortality and the subsequent prognosis in older patients undergoing curative surgery for colorectal cancer: a retrospective multicenter study

    by Shintaro Hashimoto, Tetsuro Tominaga, Keisuke Noda, Toshio Shiraishi, Mariko Yamashita, Hiroki Katayama, Shoko Tei, Taiji Hida, Hiroshi Maruta, Yuma Takamura, et al.

    Purpose Postoperative complications may affect the long-term outcomes after colorectal cancer (CRC) surgery. This multicenter study compared prognostic factors for overall survival (OS) in younger (≤ 74 years) and older (≥ 75 years) patients after curative resection for CRC, focusing on the 1-year and post-1-year outcomes. Methods We analyzed data from 1582 patients who underwent curative surgery for CRC at six hospitals between April 2016 and December 2019. Kaplan–Meier and Cox models were used to identify the risk factors for complications and survival. Results Older patients had a significantly worse overall survival (OS) and survival beyond the 1-year landmark. Postoperative complications were associated with increased 1-year mortality in both age groups. In younger patients, survival beyond 1 year was associated with a positive N status and a low BMI. In contrast, in older patients, postoperative complications remained associated with survival beyond the 1-year landmark, along with a male sex, positive N status, and poor ASA-PS. Conclusions The prolonged impact of complications on survival in older patients with CRC underscores the need for age-specific surgical strategies and proactive complication management.

  • Bio-3D printing with smooth muscle cells derived from human iPSCs via neural crest and its application for the tracheal regeneration

    by Shintaro Hashimoto, Daisuke Taniguchi, Ryoichiro Doi, Tomohiro Obata, Toshio Shiraishi, Takamune Matsumoto, Hiroshi Maruta, Keiko Akao, Satoshi Mizoguchi, Koichiro Shimoyama, et al.

    Smooth muscle cells (SMCs) derived from induced pluripotent stem cells (iPSCs) have been used for scaffold-free structures; however, their use in regenerated organs is rare and not well established. The induction of mesenchymal stem cells (MSCs) via neural crest cells (NCCs) from iPSCs offers advantages such as a large-scale cell stock. While research has progressed on the chondrogenic differentiation and regenerative medicine applications of cartilage derived from human iPSC-derived MSCs via a NCCs lineage (iNC), studies on smooth muscle, a critical tracheal component alongside cartilage, remain limited. In this study, we aimed to establish a method for generating airway smooth muscle tissue constructs using human iNCMSCs, assess their contractile function, and evaluate their regenerative potential in tracheal cartilage defects. iNCMSCs were cultured for 28 d in Dulbecco’s Modified Eagle Medium (DMEM) with fetal bovine serum (FBS), with one group receiving transforming growth factor beta 1 (TGF β 1, DMEM-TGF β 1 group) and the other group without TGF β 1 (DMEM group). SMCs markers was assessed using immunofluorescence staining. The tissue constructs were bio-3D printed using spheroids from the DMEM-TGF β 1 group and transplanted as smooth muscle patches into full-thickness defects in the rats’ tracheas. The DMEM-TGF β 1 group showed strong expression of SMCs markers such as α -smooth muscle actin, calponin, and myosin heavy chain. After 28 d post-transplant, histological evaluation confirmed graft engraftment, adequate blood flow, and epithelial layer extensions from the recipient tissues, along with well-maintained tracheal structures. This study demonstrated the feasibility of using iPSC-derived iNCMSCs to generate bio-3D printed smooth muscle constructs for tracheal regeneration. Our findings support the potential of this strategy as a novel approach for airway reconstruction, offering a scaffold-free cell-based platform for future clinical applications in tissue engineering for airway regeneration.


  • Prognostic Impact of Additional Surgery Following Endoscopic Resection for pT1 Colorectal Cancer in Patients Aged Over 80 Years

    by Kazuhide Ishimaru, Tetsuro Tominaga, Takashi Nonaka, Shintaro Hashimoto, Mariko Yamashita, Keisuke Noda, Shoko Tei, Rika Ono, Mitsutoshi Ishii, Makoto Hisanaga, et al.

    Introduction: Additional resection is recommended for pT1 colorectal cancer at risk of lymph node metastasis. This study focused on postoperative complications and the impact on long‐term outcomes in elderly patients with additional resection of pT1 colorectal cancer. Methods: We retrospectively reviewed 607 patients who underwent R0 resection for pT1 colorectal cancer between 2016 and 2023. Patients were divided into an elderly group ≥ 80 years old ( n = 108) and a nonelderly group < 80 years old ( n = 498). After propensity score matching, 108 patients in each group were matched, and clinicopathological features and prognosis were analyzed. Results: Before matching, the elderly group included more females ( p = 0.017) and showed a lower body mass index ( p = 0.008) and higher frequencies of poor performance status ( p = 0.001), comorbidities ( p < 0.001), and postoperative complications ( p = 0.002). After matching, postoperative complications were more frequent in the elderly group (28.7% vs. 15.7%, p = 0.032). Overall survival was significantly poorer in the elderly group with or without postoperative complications (78.0% vs. 91.8%, respectively; p = 0.037%), but not for the nonelderly group (91.7% vs. 85.0%, respectively; p = 0.706), and no differences were seen in recurrence‐free survival. Conclusion: Additional resection in patients ≥ 80 years old with poor performance status carries a high risk of postoperative complications and poor prognosis. Adequate perioperative management is essential, and indications for additional resection should be carefully evaluated.